Formulation Philosophy

We don't formulate products.
We engineer clinical outcomes.

39 Protocols·7 Clinical Categories·GMP Certified
The Problem

The Problem With Chemical Peels

Most chemical peels on the Indian market ship without published concentrations. Doctors apply products with “proprietary blends” — a euphemism for opacity. Single-pathway formulations that address one mechanism while ignoring three others. We find this unacceptable.

When a dermatologist cannot verify every active agent in the formulation, they are not prescribing — they are guessing. Clinical outcomes demand precision, not faith in a label.

Laboratory research and formulation analysis
Our Approach

Named Formulation Systems

Every Prodermic protocol is built around a named formulation system — a branded methodology that defines the mechanism, the active architecture, and the clinical endpoint.

prodermic 580 · Yellow Peel

Quad-Pathway Depigmentation™

Four active agents attacking melanin synthesis at different biochemical points. Tyrosinase inhibition. Melanin transfer disruption. Epidermal turnover acceleration. Antioxidant conversion.

View Protocol
prodermic 420 · Black Peel

Carbon Detox Architecture™

Activated carbon matrix combined with a controlled acid delivery system. Deep-pore adsorption. Sebum normalization. Toxin clearance without compromising barrier integrity.

View Protocol
prodermic 590 · Glutathione Peel

Master Antioxidant Protocol™

Glutathione-led eumelanin-to-pheomelanin conversion supported by multi-acid synergy. The body's master antioxidant, deployed at clinical concentrations.

View Protocol
prodermic 460 · Acne Protocol

Dual-Keratolytic System™

Two lipophilic keratolytic agents working in concert. Comedolytic action meets antibacterial efficacy. Resorcinol + Salicylic Acid in calibrated proportions for inflammatory and non-inflammatory acne.

View Protocol
prodermic 612 · TCA Protocol

Controlled-Depth Resurfacing™

Precision TCA delivery with acid modulation buffer. Controlled frosting endpoints. Predictable depth penetration for dermal remodeling in experienced hands.

View Protocol
Formulation Strategy

Why Synergy Matters

Single Agent
  • One active ingredient
  • One biochemical pathway
  • One mechanism of action
  • Limited efficacy ceiling
  • Diminishing returns above threshold
35% efficacy
vs
Multi-Agent Synergy
  • Multiple active agents
  • Multiple biochemical pathways
  • Amplified combined outcomes
  • Lower individual concentrations
  • Higher combined efficacy
multi-agent synergy
Molecular science and multi-agent synergy
Documented Outcomes

Clinical Validation

Standardized photography. Controlled protocols. Measurable outcomes. Results are representative of individual cases and may vary.

Before580 Yellow Peel before treatment
After580 Yellow Peel after treatment
580 Yellow Peel
Fitzpatrick IV4 sessions8 weeks
Before421 Black Peel before treatment
After421 Black Peel after treatment
421 Black Peel
Fitzpatrick III5 sessions10 weeks
Before565 Melasmonil Peel before treatment
After565 Melasmonil Peel after treatment
565 Melasmonil Peel
Fitzpatrick IV6 sessions12 weeks

All patients provided informed consent for photography. Images unedited except standard color calibration. Individual outcomes depend on compliance, skin type, and condition severity.

Fitzpatrick III–V Optimized

Built For Indian Skin

Our formulations are optimized for Fitzpatrick III–V skin types prevalent in the Indian subcontinent. Every protocol accounts for higher melanin density, post-inflammatory hyperpigmentation risk, and the specific environmental factors of tropical climates.

This is not Western dermatology repackaged. This is formulation science designed from the ground up for the skin types we treat every day.

See the full protocol library.

39 clinical-grade formulations with full ingredient transparency. Filter by indication, product type, or browse the complete catalogue.